Add BrightSurf on Google Email

Human-Relevant Ptpn6 mutation reveals complex links between immunity, metabolism and liver aging

A new study published in Aging reveals that a mutation affecting the immune and metabolic regulator SHP-1 reshapes liver function during aging, showing improved glucose metabolism can coexist with immune-cell accumulation and liver fibrosis. The findings separate liver inflammation and fibrosis from insulin resistance, obesity and lipi...

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 16, 2026

Rare Coombs-negative hemolytic anemia reported following pembrolizumab treatment

A new case report describes a 68-year-old woman with stage IV lung adenocarcinoma who developed severe hemolysis after receiving pembrolizumab, despite a negative Coombs test. The patient's hemoglobin declined from 11-12 g/dL to 6.4 g/dL, and laboratory markers of hemolysis improved with corticosteroid treatment. The case highlights th...

SourceImpact Journals LLC·JournalOncoscience·TypeCase study·DateSep 10, 2026

Restoring MHC-I expression could strengthen immune responses against CNS cancers

Researchers explored strategies to restore MHC-I expression in CNS cancers to make them more visible to the immune system. Approaches include epigenetic therapies, AAV vectors, PCSK9 inhibition, and modifying the tumor microenvironment. However, efficient delivery, antigen processing, and a limited neoantigen repertoire remain signific...

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateSep 9, 2026

Three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease

Researchers found three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease, suggesting a potential treatment. The extracts, including Uncaria rhynchophylla, Gardenia jasminoides, and Scutellaria baicalensis, improved cell viability and mitochondrial function in cells with reduced VPS13C expression.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 9, 2026

MDPI revives Open Access Journal of Italian Medical Laboratory

The Open Access Journal of Italian Medical Laboratory (JDReAM) has been revived by MDPI, aiming to promote high-quality, interdisciplinary research in medicine. The journal, led by Prof. Michele Maffia and Prof. Prisco Piscitelli, publishes research addressing human health and disease from various scientific perspectives.

SourceMDPI AG·DateSep 9, 2026

Tumor-derived extracellular vesicles show promise for earlier detection of metastatic risk

Tumor-derived extracellular vesicles exhibit intrinsic organotropism and participate in establishing premetastatic niches, making them promising vehicles for targeted imaging probe delivery. However, current imaging approaches have limitations, including difficulty distinguishing between tumor-derived EVs and normal host cell-derived EVs.

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateSep 1, 2026

Tumor-infiltrating lymphocyte therapy offers a promising approach for treating solid tumors

Tumor-infiltrating lymphocyte therapy has shown potential in several types of solid tumors, including metastatic melanoma, breast cancer, and ovarian cancer. Despite challenges, the approach has favorable clinical outcomes, and researchers are exploring combination strategies and advanced technologies to improve treatment durability.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateAug 31, 2026

Targeting LRG1 could open new paths for cancer therapy

A review suggests targeting LRG1 could provide a new approach to cancer therapy, with extracellular blockade and intracellular degradation potentially addressing different components of LRG1 biology. This could complement established anti-angiogenic treatments and enhance apoptosis in cancer cells.

SourceImpact Journals LLC·JournalOncoscience·TypeNews article·DateAug 26, 2026

International Molecular Tumor Board explores personalized treatment strategies for a patient with multiple primary cancers

A new precision oncology paper presents a case of a 48-year-old woman with multiple primary cancers, including breast cancer, basal cell carcinoma, ovarian carcinoma, colon cancer, and small bowel adenocarcinoma. The study demonstrates how an international molecular tumor board developed personalized treatment recommendations based on ...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateJul 22, 2026